04Jun
Cannabis-Derived Ingredients in FDA-Regulated Products: More Questions than Answers at FDA’s May 2019 Public Hearing
As most folks with any interest in the burgeoning cannabidiol (CBD) industry likely know, on May 31, 2019, the Food and Drug Administration held a public hearing “to obtain scientific data and information about the safety, manufacturing, product...
By:
Mintz - Consumer Product Safety Viewpoints
Related
As we previously reported, Nevada has enacted a personal leave law, which, effective January 1, 2020...
Read More >
Let’s face it – your dealership’s employee handbook is likely out of date, even if you just updat...
Read More >
In the course of the “Panama Paper” scandal, Directive (EU) 2015/849 on the prevention of the use ...
Read More >
Overview - For many years, the name of the game in retirement planning for income and estate tax pu...
Read More >
Shareholder Representative Services LLC v. RSI Holdco, LLC, C.A. No. 2018-0517-KSJM (Del. Ch. May 29...
Read More >
There has been a new development in the Xerox and Fujifilm (“Fuji”) litigation: Justice Ostrager ...
Read More >